Lung cancerMetformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations - METLUNG - Instituto Nacional de Cancerologia de Mexico
Alectinib Pharmacokinetic in Patients With NSCLC - Alectinib - Instituto Nacional de Cancerologia de Mexico
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC - Glutamine - Instituto Nacional de Cancerologia de Mexico
Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients - Pulmonary Rehabilitation - Instituto Nacional de Cancerologia de Mexico
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. - Nitroglycerin - Instituto Nacional de Cancerologia de Mexico
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment - Beamion LUNG 2 - Boehringer Ingelheim
